A REVIEW ON: “TARGETED CANCER THERAPY & THEIR DRUGS”

A REVIEW ON: “TARGETED CANCER THERAPY & THEIR DRUGS”

Registration ID: IJNRD_183654

Published ID: IJNRD2210161

DOI: Click Here to Get

Shubhangi Balasaheb Mahandule , Mayur Kisan Kolhatkar , Shruti Sonawane , Saurabh Rajendra Jagtap , Sonali Anil mane

cancer, metastatic, chemotherapy, Targeted therapy, radiation.

People with advanced and metastatic non-small cell lung cancer (NSCLC) that responds to targeted therapies or check point inhibitors now routinely survive for three or four years after diagnosis, and a lucky few live substantially longer. Chemotherapy and targeted therapy are both treatments that attacks cancer cells. Targeted therapy is less toxic to healthy cells than chemotherapy. Both options are often done in conjunction with other treatments, such as radiation. Before you have some types of targeted drugs you might need to have tests using some of your cancer cells or a blood sample. This is to find out whether the treatment is likely to work. These tests look for changes in certain proteins or genes. Your cancer specialist can tell you if this applies to your treatment.

Published Paper   E-Certificate

"A REVIEW ON: “TARGETED CANCER THERAPY & THEIR DRUGS”", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.7, Issue 10, page no.285-296, October-2022, Available :https://ijnrd.org/papers/IJNRD2210161.pdf

Volume 7 Issue 10, October-2022

Pages : 285-296

Paper Reg. ID: IJNRD_183654

Published Paper Id: IJNRD2210161

Downloads: 000121125

Research Area: Pharmacy

Country: Ahmednagar, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2210161.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2210161

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area